Antabuse and Liver function tests nos abnormal - a phase IV clinical study of FDA data

Summary:

Liver function tests nos abnormal is reported as a side effect among people who take Antabuse (disulfiram), especially for people who are male, 40-49 old, also take Effexor,.

The phase IV clinical study analyzes which people have Liver function tests nos abnormal when taking Antabuse. It is created by eHealthMe based on reports of 933 people who have side effects when taking Antabuse from the FDA, and is updated regularly.

What is Antabuse?

Antabuse has active ingredients of disulfiram. It is often used in alcoholism. eHealthMe is studying from 1,182 Antabuse users. Check the latest studies of Antabuse.

What is Liver function tests nos abnormal?

Liver function tests nos abnormal is found to be associated with 836 drugs and 190 conditions by eHealthMe. Check the latest studies of Liver function tests nos abnormal.

On Dec, 10, 2025

933 people reported to have side effects when taking Antabuse.
Among them, 17 people (1.82%) have Liver function tests nos abnormal.

Could Antabuse cause Liver function tests nos abnormal?

Among these 17 people:

What is the gender of people who have Liver function tests nos abnormal when taking Antabuse? *

female: 41.18 %
male: 58.82 %

What is the age of people who have Liver function tests nos abnormal when taking Antabuse? *

What are other drugs people take besides Antabuse? *

What are other side effects people have besides Liver function tests nos abnormal? *

Blood Bilirubin Increased: 7 people, 41.18%
Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 5 people, 29.41%
Hepatic Failure (liver failure): 5 people, 29.41%
Fatigue (feeling of tiredness): 3 people, 17.65%
Nausea (feeling of having an urge to vomit): 3 people, 17.65%
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight): 2 people, 11.76%
Hepatic Necrosis (large portions of liver die off due to severe liver disease): 2 people, 11.76%
Prothrombin Level Decreased: 2 people, 11.76%
Hepatocellular Damage (liver damage): 2 people, 11.76%
Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Antabuse and have Liver function tests nos abnormal?

- Check whether Liver function tests nos abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Antabuse:

Antabuse (1,182 reports)

Browse all side effects of Antabuse:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Liver function tests nos abnormal:

Liver function tests nos abnormal (836 drugs)

Browse all the conditions that are associated with Liver function tests nos abnormal:

Liver function tests nos abnormal (190 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on disulfiram (the active ingredients of Antabuse) and Antabuse (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.